Nuvalent
Matthew Campbell is currently the Director at Nuvalent, Inc. Prior to this role, Matthew held positions at Agios Pharmaceuticals as Associate Director and at Infinity Pharmaceuticals Inc. as Scientist and Senior Manager. Matthew also has experience at ArQule as an Analytical and at Ceimic as an Organic Extraction Lab Supervisor. Matthew studied at the College of the Holy Cross and received a BA in Chemistry.
This person is not in any teams
Nuvalent
1 followers
Nuvalent is creating precisely targeted therapies for patients with cancer designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in structure-based design, Nuvalent develops innovative small molecules with exquisite target selectivity to overcome resistance, minimize adverse events, and drive more durable responses.